Results 21 to 30 of about 4,527,439 (244)

Acute generalized exanthematous pustulosis: Epidemiology, clinical course, and treatment outcomes of patients treated in an Asian academic medical centerCapsule Summary

open access: yesJAAD International, 2021
Background: Acute generalized exanthematous pustulosis (AGEP) is a rare severe cutaneous adverse drug reaction. Although acutely patients have significant morbidity and occasional systemic involvement, the clinical course is generally self-limited.
Dawn Ai Qun Oh, MBBS, MRCP   +5 more
doaj   +1 more source

Severe cutaneous adverse reactions to anti-tuberculosis drugs in korean patients [PDF]

open access: yes, 2021
Purpose: Anti-tuberculosis drugs (ATDs) can cause severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS).
Yang, MS   +15 more
core   +1 more source

Clinical aspects and therapeutic approach of drug-induced adverse skin reactions in a quaternary hospital: a retrospective study with 219 cases [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2022
Background Adverse drug reactions are frequent, with cutaneous manifestations being the most common. In the hospital environment, the incidence of cutaneous drug reactions varies from 2% to 3%.
Júlia Chain Martins   +2 more
doaj   +1 more source

Severe cutaneous adverse reaction to telaprevir [PDF]

open access: yes, 2015
A 50-year-old woman presented with diffuse, intensely pruritic pink-red papules on her trunk and extremities three weeks after starting combination therapy with ribavirin, telaprevir, and interferon.
Nambudiri, Vinod   +2 more
core   +1 more source

Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada [PDF]

open access: yes, 2003
Although information on efficacy and adverse drug reactions is lacking, ribavirin has been used empirically for the treatment of severe acute respiratory syndrome (SARS). We report common adverse events in 110 patients with suspected or probable SARS who
Dresser, L.   +7 more
core   +1 more source

Telaprevir-related DRESS syndrome complicating hepatitis C treatment [PDF]

open access: yesJournal of Microbiology and Infectious Diseases, 2015
In chronic hepatitis C patients telaprevir attracts attention with high sustained virologic response and short term treatment however it is associated a new spectrum of adverse events, especially several cutaneous manifestations.
Süheyla Kömür   +5 more
doaj   +3 more sources

Caregiver Burden, Resilience, and Wellbeing in Cases of Severe Cutaneous Adverse Drug Reactions [PDF]

open access: yes
Background: Severe cutaneous adverse reactions (SCAR) can be traumatic and emotionally distressing for both the patients and their families. However, caregivers must also take care of themselves to prevent burnout.
Santanu Kumar Tripathi   +2 more
core   +1 more source

Clinicoepidemiological Profile of Severe Cutaneous Adverse Drug Reaction: A Retrospective Study

open access: yesBerkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2019
Background: Drug eruption were varied from mild to severe reaction. Few studies have assessed the severe cutaneous adverse drug reaction (SCADR), especially in the setting of general hospital.
Damayanti Damayanti   +5 more
doaj   +1 more source

Inadvertent provocative oral ondansetron use leading to toxic epidermal necrolysis in an HIV-infected patient

open access: yesIndian Journal of Dermatology, 2012
Toxic epidermal necrolysis (TEN) is a severe cutaneous adverse reaction to drugs, characterized by extensive detachment of epidermis and mucous membranes with a mortality of 30-40%.
Punit P Saraogi   +3 more
doaj   +1 more source

Isolated testicular tuberculosis with ethambutol cutaneous toxicity: A combination of two rare entities

open access: yesInternational Journal of Mycobacteriology, 2020
Tuberculosis (TB) is an infection that can affect any organ, affecting mainly the lungs. Isolated testicular TB is very rare. Six months of a multiple drug scheme is the mainstay of TB treatment.
Flávio Godinho Pereira   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy